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ABSTRACT
Pectin has received a widespread application in oral drug delivery system design due to 
its biodegradability, biocompatibility and non-toxicity. This study aims to formulate 
sustained-release pectinate beads with diclofenac sodium as small molecule drug model 
by means of microwave technology and pectinate nanoparticles with insulin as 
macromolecular drug. The pectinate beads were prepared by an extrusion method with 
chitosan loading internally in the pectinate beads or externally via coacervation. These 
beads were treated by microwave at 80 W for 5, 10, 21 and 40 min, and had their drug 
release examined against physicochemical changes of matrices. Treatment of pectinate 
beads by microwave did not lead to a decrease, but an increase in the extent of drug 
released at 4 h of dissolution. The drug release of pectinate beads was reduced only upon 
core loading of chitosan on treating the externally coacervated pectinate-chitosonium 
beads with microwave. The treatment of chitosan-pectinate matrix by microwave 
brought about an increase in the extent of drug released unlike those of pectinate- 
chitosonium beads. Apparently, the loading of chitosan into the interior of pectinate 
matrix could effectively retard the drug release without subjecting the beads to the 
treatment of microwave. The microwave was merely essential to reduce the release of 
drug from pectinate beads when the chitosan was introduced to the pectinate matrix by 
means of coacervation. The calcium pectinate-insulin nanoparticles were prepared by 
ionotropic gelation method, with alginate, sodium chloride or Tween 80 as additive. 
Their in vitro physicochemical, drug release and in vivo blood glucose lowering 
characteristics were evaluated. Spherical calcium pectinate-insulin nanoparticles were 
characterized by size, zeta potential, insulin content and insulin association efficiency of
348.4 ± 12.9 nm, -17.9 ± 0.8 mV, 8.4 ± 1.0% and 63.8 ± 7.4%, respectively. They 
released less than 25% insulin following 24 h in simulated intestinal medium and 
exhibited delayed blood glucose lowering effect in rats. Incorporation of solubilizer 
sodium chloride or Tween 80 into nanoparticles did not enhance blood glucose lowering 
capacity owing to sodium chloride reduced matrix insulin content and Tween 80 
interacted with water and had its blood glucose dilution effect negated. Combination of 
nanoparticles with alginate gel to allow prolonged intestinal residence and more insulin 
release did not enhance their blood glucose lowering capacity because of calcium 
alginate-cross-linked gel formation that could retard insulin release and migration into 
systemic circulation. Physicochemical responses of additives in vivo affected blood 
glucose regulation property of pectin-insulin nanoparticles.
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